SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is experiencing significant momentum and heavy short-covering as investors closely monitor the REGAL Phase 3 trial for the 80th clinical event. The community is actively discussing the potential for a curative AML treatment, the implications of successful immunotherapy data, and increasing speculation regarding strategic partnerships or high-stakes buyout interest.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is in the spotlight as investors weigh the company's aggressive pivot toward AI infrastructure against the financial pressure of mounting capital expenditures, a strategy that has sparked intense debate over the firm's long-term value. Market participants are closely watching the stock ahead of earnings, particularly as community sentiment remains polarized between those betting on an AI-driven turnaround and critics wary of the company's historical performance and the risks associated with the Chinese equity market.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors await clarity on the FDA's regulatory decision, with the community split between those anticipating a PDUFA extension for an amended BLA and those fearing a complete response letter. Shareholders are actively debating the impact of a recent activist letter from Kaos Capital and the potential for a short squeeze if regulatory news provides a path forward.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending as investors react to a significant new partnership with Google that includes a major custom-chip agreement and a multibillion-dollar warrant deal. While the community is debating the long-term potential of this expansion against concerns about share dilution and the stock's recent volatility, many are closely monitoring its performance ahead of the upcoming earnings report.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Canadian Solar is trending as investors bet on a potential short squeeze, fueled by significant institutional buying and anticipation that U.S. manufacturing growth will unlock 45X tax credit value. Community discussion remains heavily focused on alleged market manipulation and undervalued assets, while some shareholders push for corporate action to realize the firm's true valuation.

Subsquid Network is an innovative decentralized data lake and query engine designed to offer developers performant and permissionless access to data, aiming to build a neutral and open internet rooted in Web3 principles. Secured by ZK proofs, the Subsquid network boasts a modular architecture that enables exceptional scalability and developer convenience optimized for blockchain indexing, dApp development, and analytics.  Subsquid is a response to unscalable and rigid monolithic indexing frameworks that had previously gained popularity and market traction among Web3 developers. Today, these frameworks are struggling to adapt in a rapidly evolving blockchain environment. Additionally, the network serves as a highly efficient and decentralized alternative to centralized infrastructure firms, including large RPC and API providers.

Investors are actively debating the long-term utility of SQD as a decentralized data infrastructure layer, with proponents highlighting its faster, more cost-effective indexing capabilities compared to competitors like The Graph. While some community members remain skeptical of the project's price action and labeling it a speculative asset, others view it as a key infrastructural component for Agentic AI and blockchain finance.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is currently trending as investors weigh strong revenue growth for Briumvi against an earnings miss caused by planned R&D investments, while buyout speculation continues to drive community discussion about a potential acquisition premium. With the stock holding key levels, traders are focused on the company's path to a billion-dollar revenue run rate and upcoming pipeline milestones.

DigitalOcean Holdings, Inc. engages in the provision of providing cloud infrastructure. It operates through the following geographical segments: United States, Netherlands, Germany, Canada, Singapore, and Other. The company was founded in 2012 and is headquartered in Broomfield, CO.

DigitalOcean Holdings Inc

DigitalOcean is trending as investors react to a significant $800 million upsized public stock offering, with the community actively debating whether the dilution is a strategic move to fund data center expansion or a potential signal to trim positions after the stock's recent strong rally.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce shares are drawing attention as the market debates the long-term impact of AI on enterprise software, with community members closely tracking recent analyst downgrades against management's heavy stock buyback activity and enterprise deal wins. Sentiment remains divided between concerns over AI-driven disruption and bullish conviction that the company's data moats and platform stickiness will drive future growth.

Ethena

The Ethena community is actively discussing structural upside and massive NAV discounts, with significant conversation focused on the concentration of ENA tokens backing each share of the linked public stock. Traders are closely monitoring the token's price action as a gauge for potential rallies, while speculating on how institutional relationships and treasury accumulation strategies might drive long-term value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ABERDEEN INVESTMENTS ANNOUNCES 10-FOR-1 FORWARD SHARE SPLIT OF ABRDN PHYSICAL PLATINUM SHARES ETF (PPLT) AND 5-FOR-1 FORWARD SHARE SPLIT OF ABRDN PHYSICAL PALLADIUM SHARES ETF (PALL)

ABERDEEN INVESTMENTS ANNOUNCES 10-FOR-1 FORWARD SHARE SPLIT OF ABRDN PHYSICAL PLATINUM SHARES ETF (PPLT) AND 5-FOR-1 FORWARD SHARE SPLIT OF ABRDN PHYSICAL PALLADIUM SHARES ETF (PALL) ABERDEEN...

Best-Performing ETFs of Last Week: Commodity Wins

UNG, PLTM and PALL led ETF gains last week as natural gas, platinum and palladium surged amid winter shocks and rising geopolitical risks.

ETF Stories to Rule in 2026

ETF themes to watch in 2026: S&P 500 strength, metals momentum, banks, AI, robotaxis, clean energy and global ETFs like SPY, COPX, TAN.

 6 ETF Predictions for 2026

2026 could favor SPY, SLV, KBWB, TAN & global ETFs as AI, metals, banks and clean energy shape the next leg of market gains.

Santa Rally for Metal ETFs as Gold, Silver & Platinum Hit Highs

Gold, silver and platinum hit record highs as safe-haven and industrial demand surged, boosting GLD, SLV, PPLT, PALL into year-end.

Palladium ETF (PALL) Hits New 52-Week High

Palladium ETF PALL just it a 52-week high on safe-haven demand and rate cut hopes. Can the rally last? 

Best-Performing ETF Areas of Last Week That Are Up At Least 10%

Platinum (PLTM, PPLT), Palladium (PALL), Lithium (LITP), and Silver (SLVR) ETFs all jumped 10%+ last week despite weak Wall Street.

Why is Palladium Struggling at the $1,000 Level?

Palladium is a rare precious metal that comes primarily from Russia and South Africa. After reaching a high of $3,425 per ounce in early 2022, the price plunged and was trading on either side of $1,000 per ounce in March 2025.

Abrdn Palladium ETF Trust - Units of fractional undivided beneficial interest

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$24.45
Prev Close	$24.20
Open	$24.50
Dividend Yield	N/A
50-Day Moving Average	$23.35
Beta	N/A
Avg. Volume	625,905.92
PE Ratio	N/A

52-Week High	$39.48
52-Week Low	$19.70
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info